Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70076 - 70100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CSTF2T	23283	downregulated	Silicon Dioxide analog results in decreased expression of CSTF2T mRNA	10q21.1	A24194
Silicon dioxide	Approved	CSTF3	1479	downregulated	Silicon Dioxide analog results in decreased expression of CSTF3 mRNA	11p13	A24195
Silicon dioxide	Approved	CTAG1A	246100	upregulated	Silicon Dioxide analog results in increased expression of CTAG1A mRNA	Xq28	A24194
Silicon dioxide	Approved	CTBS	1486	downregulated	Silicon Dioxide analog results in decreased expression of CTBS mRNA	1p22.3	A24195
Silicon dioxide	Approved	CTBS	1486	downregulated	Silicon Dioxide results in decreased expression of CTBS mRNA	1p22.3	A24196
Silicon dioxide	Approved	CTDSP2	10106	downregulated	Silicon Dioxide analog results in decreased expression of CTDSP2 mRNA	12q14.1	A24195
Silicon dioxide	Approved	CTDSPL	10217	downregulated	Silicon Dioxide results in decreased expression of CTDSPL mRNA	3p22.2	A24196
Silicon dioxide	Approved	CTGF	1490	upregulated	Silicon Dioxide results in increased expression of CTGF mRNA	6q23.2	A24196 A24198
Silicon dioxide	Approved	CTH	1491	downregulated	Silicon Dioxide analog results in decreased expression of CTH mRNA	1p31.1	A24195
Silicon dioxide	Approved	CTH	1491	downregulated	Silicon Dioxide results in decreased expression of CTH mRNA	1p31.1	A24196
Silicon dioxide	Approved	CTNNAL1	8727	upregulated	Silicon Dioxide analog results in increased expression of CTNNAL1 mRNA	9q31.3	A24195
Silicon dioxide	Approved	CTNNBIP1	56998	downregulated	Silicon Dioxide analog results in decreased expression of CTNNBIP1 mRNA	1p36.22	A24195
Silicon dioxide	Approved	CTPS1	1503	upregulated	Silicon Dioxide analog results in increased expression of CTPS1 mRNA	1p34.2	A24195
Silicon dioxide	Approved	CTRL	1506	upregulated	Silicon Dioxide analog results in increased expression of CTRL mRNA	16q22.1	A24195
Silicon dioxide	Approved	CTSF	8722	downregulated	Silicon Dioxide analog results in decreased expression of CTSF mRNA	11q13.2	A24195
Silicon dioxide	Approved	CTSL	1514	upregulated	Silicon Dioxide analog results in increased expression of CTSL mRNA	9q21.33	A24195
Silicon dioxide	Approved	CTSS	1520	downregulated	Silicon Dioxide analog results in decreased expression of CTSS mRNA	1q21.3	A24195
Silicon dioxide	Approved	CTTNBP2	83992	downregulated	Silicon Dioxide analog results in decreased expression of CTTNBP2 mRNA	7q31.31	A24195
Silicon dioxide	Approved	CTTNBP2	83992	upregulated	Silicon Dioxide analog results in increased expression of CTTNBP2 mRNA	7q31.31	A24194
Silicon dioxide	Approved	CUL3	8452	upregulated	Silicon Dioxide results in increased expression of CUL3 mRNA	2q36.2	A24196
Silicon dioxide	Approved	CUTC	51076	upregulated	Silicon Dioxide results in increased expression of CUTC mRNA	10q24.2	A24196
Silicon dioxide	Approved	CX3CR1	1524	downregulated	Silicon Dioxide analog results in decreased expression of CX3CR1 mRNA	3p22.2	A24195
Silicon dioxide	Approved	CXCL1	2919	upregulated	Silicon Dioxide analog results in increased expression of CXCL1 mRNA	4q13.3	A24194 A24195
Silicon dioxide	Approved	CXCL1	2919	upregulated	Silicon Dioxide results in increased expression of CXCL1 mRNA	4q13.3	A24203 A24196
Silicon dioxide	Approved	CXCL10	3627	upregulated	Silicon Dioxide analog results in increased expression of CXCL10 mRNA	4q21.1	A24194

Displaying entries 70076 - 70100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability